Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Nitric Oxide in CDH with Early Pulmonary Hypertension
NCT07247240Phase 4Not yet recruiting
- Sponsor
- Asan Medical Center
- Start
- Nov 2025
- Primary completion
- Dec 2028
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
A Phase 4 trial of nitric oxide in pulmonary hypertension (PH), sponsored by Asan Medical Center. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
nitric oxide
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT07247240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07247240.